Altropane

LifeTech Capital has published a research report on Navidea Biopharmaceuticals (NYSE: NAVB) after the company announced yesterday that the company has entered into a deal with Alseres Pharmaceuticals (formerly Boston Life Sciences). In the report, LifeTech writes, "After market close yesterday,...